-
Apr 19, 2024 | 
invesbrain.com | Jan Nieuwenhuijs |Alex Hoffman |Tyler Durden
By Jan Nieuwenhuijs of Gainesville Coins Recently the World Bank released a handbook for asset managers on why to invest in gold. At Gainesville Coins I have written numerous articles on gold revaluation accounts and how these can be deployed by central banks to absorb losses in case of emergency. The World Bank has taken notice of my research as they allude to this practice in a chapter on reserve accounting and reference to my work.
-
Mar 8, 2024 | 
invesbrain.com | Alex Hoffman |David Buckland |Chris Clow
A new report from the National Academies of Science, Engineering, and Medicine (NASEM), An Updated Measure of Poverty: (Re)Drawing the Line, has hit Washington with something of a splash. Its proposals deserve a warm welcome across the political spectrum. Unfortunately, they are not always getting it from the conservative side of the aisle.
-
Feb 2, 2024 | 
invesbrain.com | Alex Hoffman |Elizabeth Anderson |Tyler Durden |Laura Rodini
Authored by Jeffrey Tucker via The Brownstone Institute, The United States has the distinction the world over for being a home to the First Amendment, which guarantees free expression. And yet a mere seven years after its ratification in 1791, Congress violated it in the most severe way with the "Alien and Sedition Acts" of 1798, which made it a crime to engage in "false, scandalous, and malicious writing" against government officials.
-
Jan 19, 2024 | 
invesbrain.com | Tyler Durden |Simon Mugo |Alex Hoffman
After starting off the week with whimper, renewed hopes for a soft Goldilocks landing as well as two consecutive upgrades of Apple have not only reversed the bitter taste from the preceding two downgrades (today the company was added to Evercore ISI's tactical outperform, following yesterday's BofA upgrade which fueled the best day for Apple since May), but have also sparked "banging" trader sentiment which pushed US futures higher in premarket trading while lifting the Nasdaq 100 to a...
-
Jan 19, 2024 | 
invesbrain.com | Tyler Durden |Simon Mugo |Alex Hoffman |Kyle LaHucik
After starting off the week with whimper, renewed hopes for a soft Goldilocks landing as well as two consecutive upgrades of Apple have not only reversed the bitter taste from the preceding two downgrades (today the company was added to Evercore ISI's tactical outperform, following yesterday's BofA upgrade which fueled the best day for Apple since May), but have also sparked "banging" trader sentiment which pushed US futures higher in premarket trading while lifting the Nasdaq 100 to a...
-
Jan 19, 2024 | 
invesbrain.com | Simon Mugo |Alex Hoffman |Kyle LaHucik
If you're in neuroscience, you've probably heard of him. Few people have dipped a hand in as many neuroscience biotechs and government research units as Steve Paul, and he's going out (nearly) on top. The decadeslong CNS drug discovery and development veteran retired from his post as chief scientific officer and president of R&D at Karuna Therapeutics on Jan. 16, just weeks after inking a $14 billion exit to Bristol Myers Squibb.
-
Jan 19, 2024 | 
invesbrain.com | Alex Hoffman |Kyle LaHucik |Tyler Durden
If you're in neuroscience, you've probably heard of him. Few people have dipped a hand in as many neuroscience biotechs and government research units as Steve Paul, and he's going out (nearly) on top. The decadeslong CNS drug discovery and development veteran retired from his post as chief scientific officer and president of R&D at Karuna Therapeutics on Jan. 16, just weeks after inking a $14 billion exit to Bristol Myers Squibb.
-
Jan 15, 2024 | 
matr.net | Alex Hoffman
Charlie Stortz is the vice president at AMP Global Strategies and a lifetime Griz fan. His mission is to create a safer environment for those attending events with large crowds. His company’s technology uses advanced algorithms to pick out a gunshot from the noise of a big gathering. Stortz’s technology is gaining strong interest from major leagues like the NFL and the MLB to create a safer environment for sports fans.
-
Oct 20, 2023 | 
invesbrain.com | Lance Roberts |Alex Hoffman |Kenny Fisher
→ Ex- Olema Oncology chief Cyrus Harmon has resurfaced as CEO of Vilya, a Seattle-based macrocycle biotech from David Baker's lab that raised a $50 million Series A last August. Harmon co-founded Olema in 2007 and he moved into the role of chief technology officer when Sean Bohen was hired as CEO three years ago. He then shifted to chief research officer until Olema restructured in March and laid off about 25% of its staff.
-
Oct 20, 2023 | 
invesbrain.com | Alex Hoffman |Kenny Fisher |Tyler Durden
→ Ex- Olema Oncology chief Cyrus Harmon has resurfaced as CEO of Vilya, a Seattle-based macrocycle biotech from David Baker's lab that raised a $50 million Series A last August. Harmon co-founded Olema in 2007 and he moved into the role of chief technology officer when Sean Bohen was hired as CEO three years ago. He then shifted to chief research officer until Olema restructured in March and laid off about 25% of its staff.
